Novel partial agonists for the histamine H3 receptor with high in vitro and in vivo activity

Journal of Medicinal Chemistry

Volumn 42, Issue 20, 1999, Pages 4269-4274

  Sasse, Astrid ^a   Stark, Holger ^a   Reidemeister, Sibylle ^a   Hüls, Annette ^a   Elz, Sigurd ^a   Ligneau, Xavier ^b   Ganellin, C Robin ^c   Schwartz, Jean Charles ^d   Schunack, Walter ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Laboratoire Bioprojet   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CENTRE PAUL BROCA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H1 RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENCY; GUINEA PIG; HISTAMINE RELEASE; INTESTINE MUCOSA; INTRINSIC SYMPATHOMIMETIC ACTIVITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC INHIBITION; SYNAPTOSOME;

ANIMALS; CEREBRAL CORTEX; ELECTRIC STIMULATION; ETHERS; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; ILEUM; IMIDAZOLES; METHYLHISTAMINES; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTOSOMES;

EID: 0033533749     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm991068w     Document Type: Article

References (29)

1. 3 (Ant)Agonists. Int. Pat. Appl. WO 96/29 315, Sept 26, 1996.
2. 3) of Histamine Receptor. Nature (London) 1983, 302, 832-837.
3. 3-Receptors. Neuroscience 1985, 15, 553-562.
4. 3-Receptors. Neuroscience 1987, 23, 149-157.
5. Hill, S. J.; Ganellin, C. R.; Timmerman, H.; Schwartz, J.-C.; Shankley, N. P.; Young, J. M.; Schunack, W.; Levi, R.; Haas, H. L. International Union of Pharmacology. XIII. Classification of Histamine Receptors. Pharmacol. Rev. 1997, 49, 253-278 and literature cited therein.
6. 3-Receptor Antagonists. Drugs Future 1996, 21, 507-520.
7. 3 Receptor Agonists and Antagonists. Trends Pharmacol. Sci. 1998, 19, 177-183.
8. 3-Receptors. Nature (London) 1987, 327, 117-123.
9. 3 Receptor Agonist, 4-(1H-Imidazol-4-ylmethyD-piperidine. J. Med. Chem. 1994, 37, 332-333.
10. 3 Receptor Agonist. J. Pharmacol. Exp. Ther. 1992, 263, 304-310.
11. 3 Receptor Agonists. Bioorg. Med. Chem. Lett. 1992, 2, 77-78.
12. 3 Receptors. Bioorg. Med. Chem. Lett. 1992, 2, 1231-1234,
13. 3-Receptor. Eur. J. Med. Chem. 1992, 27, 511-517.
14. 3 Receptor Agonists. J. Med. Chem. 1995, 38, 4070-4079.
15. 3 Receptor Heterogeneity? J. Pharmacol. Exp. Ther. 1996, 276, 1009-1015.
16. 3 Receptor Heterogeneity? Naunyn-Schmiedeberg's Arch. Pharmacol. 1996, 353, 482-488.
17. 3-Receptor Ligands on Guinea-Pig Ileum. Proceedings of the British Pharmacological Society, Edinburgh, U.K., Sept 2-4, 1997; P153.
18. 3 Receptor. J. Med. Chem. 1996, 39, 1220-1226.
19. 3-Receptor Antagonists: Synthesis, Capillary Electrophoresis, and in Vitro and Oral in Vivo Activity. J. Med. Chem. 1999, 42, 593-600.
20. (a) Shioiri, T.; Ninomiya, K.; Yamada, S. Diphenylphosphoryl Azide. A New Convenient Reagent for a Modified Curtius Reaction and for the Peptide Synthesis J. Am. Chem. Soc. 1972, 94, 6203-6205.
21. (b) Ninomiya, K.; Shioiri, T.; Yamada, S. Diphenyl Phosphorazidate (DPPA). A New Convenient Reagent for a Modified Curtius Reaction. Tetrahedron 1974, 30, 2151-2157.
22. Williamson, A. About the Theory of the Formation of Ethers. Ann. Chem. 1851, 77, 37-49.
23. 3 Ligands. Meth. Find. Exp. Clin. Pharmacol. 1992, 14, 747-751.
24. 3 Receptor Models. Br. J. Pharmacol. 1994, 112, 1043-1048.
25. 2 Receptors. J. Med. Chem. 1992, 35, 2231-2238.
26. 3 Receptors in Rat Brain Areas. Neuroscience 1993, 52, 169-189.
27. 3 Receptor Antagonists with High in Vitro and Oral in Vivo Activity. J. Med. Chem. 1996, 39, 1157-1163.
28. 3-Receptor Agonists. Pharmazie 1998, 53, 433-437.
29. 3 Receptors. J. Pharmacol. Exp. Ther. 1994, 271, 452-459.